Local view for "http://purl.org/linkedpolitics/eu/plenary/2002-10-22-Speech-2-009"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20021022.1.2-009"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
". – Mr President, I should like to offer my congratulations to the two rapporteurs on an enormously complicated and difficult task. They have highlighted – as will I – the importance of this industry a major employer of this industrial research base. It is so important to keep in the European Union, both for the European Union and, above all, for consumers who want safe, effective and affordable medicines. Added to that are the complex needs of the sectors in the industry, of which there are at least three: the in-patent sector, the generic sector and the over-the-counter sector. Many of the amendments are seeking to strike the correct balance between them. We have to encourage the in-patent sector to develop new medicines but the generic sector also provides affordable medicines. If you add to this the whole question of access and affordability on a global scale, you can see just how complex an area this is.
I want to draw attention to just three points. One is the authorisation procedure. I am urging colleagues to accept duality, at least in the immediate future. Mrs Grossetête perhaps needs to re-examine the whole question of the centralised procedure and access. The fact that medicines are authorised does not mean that they are automatically placed on the market. This applies particularly to veterinary medicines. In their case I really believe that duality should continue.
On the question of advertising and consumer information, I urge Parliament to accept the amendment that asks the Commission to look again at this issue. The Commission is right – information is available to some, but not to all. That is almost beyond our control.
On data exclusivity, the balance that the Committee on the Environment, Public Health and Consumer Policy has come up with is the right one. I hope that Parliament will look at it sensibly. We are going to have an important second reading and possibly a conciliation, so we still have time to try and get this even more right that we have done so far."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples